[1]
A. G. de O. Gonçalves, “HIGH-COST MEDICATIONS IN THE SUS: COPD PATIENTS IN A VULNERABLE STATE”, EIC, pp. 211–219, Sep. 2025, doi: 10.56238/edimpacto2025.028-022.